We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Diagnostic and Therapeutic Use of Radioisotopes for Bone Disease in Prostate Cancer: Current Practice.
- Authors
Chandy, Steffy Mary; Kelkar, Girvar Singh; Bodana, Paras; Gupta, Revathi A.
- Abstract
Nuclear medicine techniques continue to be important non-invasive imaging tools assisting to the diagnosis, monitoring and in other some cases like treatment of prostate cancer. Bone scintigraphy was the premier modality to have an extensive role in the staging of prostate cancer and has remained an integral tool for over three decades in the assessment of newly diagnosed disease or in follow-up staging. Therapeutic treatment and palliation of disseminated disease, particularly in the skeleton, has also been successful with several radioisotopes including strontium-89 chloride. Despite advances in nuclear medicine techniques and molecular imaging technology such as positron emission tomography (PET) and radioimmuno scintigraphy, bone scintigraphy still remains the gold standard in the assessment of osseous metastatic disease in prostate cancer. Thus, it is important to continually review the modalities that have remained important over time and not just to focus on newer technologies.
- Subjects
PROSTATE cancer treatment; RADIOISOTOPE therapy; TREATMENT of bone diseases; RADIOSCOPIC diagnosis; THERAPEUTIC use of nuclear medicine; MEDICAL practice
- Publication
International Journal of Pharmacy & Life Sciences, 2018, Vol 9, Issue 2, p39
- ISSN
0976-7126
- Publication type
Article